Between Bedside and Bench
Nature Medicine 14, 1155 - 1156 (2008)
doi:10.1038/nm1108-1155
Graft-versus-host disease: suppression by statins
Raewyn Broady1 & Megan K Levings1
Abstract
Two big challenges of transplantation biology are controlling the reaction of the graft to the host after hematopoietic stem cell transplantation and preventing rejection of donor organs by the host. Raewyn Broady and Megan K. Levings discuss the first challenge, examining studies suggesting that statins might be helpful to control graft-versus-host disease. Kathryn Wood tackles the second challenge in the context of the 'Edmonton protocol', a procedure that can restore the ability to control blood glucose in people with type 1 diabetes—but only in the short term.
- Raewyn Broady is in the Department of Medicine and Megan K. Levings is in the Department of Surgery, University of British Columbia and Immunity and Infection Research Centre, Vancouver Coastal Health Research Institute. 2660 Oak Street, Vancouver, V6H 3Z6 British Columbia, Canada. e-mail: mlevings@interchange.ubc.ca
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Immunomodulation: a new role for statins?Nature Medicine News and Views (01 Dec 2000)
Effects of Calcium Channel and Renin?Angiotensin System Blockade on Intravascular and Neurohormonal Mechanisms of Hypertensive Vascular DiseaseAmerican Journal of Hypertension News and Views
Molecular multitasking: statins lead to more arteries, less plaqueNature Medicine News and Views (01 Sep 2000)
